Skip to content
drillr.ai
Sign up

DMRA

Damora Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$30.06
+7.36%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue79.0K—181.0K830.0K490.0K
Gross Profit(79.0K)—(181.0K)(830.0K)(490.0K)
Operating Expenses
R&D Expense248.4M201.2M6.4M23.8M48.2M
SG&A Expense22.3M9.7M10.3M11.9M12.5M
General & Admin Expense12.8M9.7M———
Selling & Marketing Expense—————
Other Expenses—————
Total Operating Expenses270.6M210.9M16.7M35.6M60.7M
Cost and Expenses270.7M210.9M16.9M36.5M61.2M
Operating Income (EBIT)(270.7M)(210.9M)(16.9M)(36.5M)(61.2M)
Non-Operating
Interest Income8.2M1.2M844.0K1.7M722.0K
Interest Expense—————
Net Interest Income8.2M1.2M844.0K1.7M722.0K
Other Non-Op Income/Expense8.2M1.1M(4.5M)(1.9M)(417.0K)
Non-Operating Income (excl Interest)(4.1M)(1.1M)4.5M1.9M417.0K
EBT (Pre-Tax Income)(262.5M)(209.8M)(21.4M)(38.3M)(61.6M)
Income Tax Expense341.0K50.0K41.0K——
Bottom Line
Net Income(262.8M)(209.8M)(21.4M)(38.3M)(61.6M)
Earnings from Cont. Ops(262.8M)(209.8M)(21.4M)(38.3M)(61.6M)
Earnings from Discont. Ops—————
Bottom Line Net Income(262.8M)(209.8M)(21.4M)(38.3M)(61.6M)
Per Share
Basic EPS($124.78)($152.99)($18.53)($36.08)($60.63)
Diluted EPS($124.78)($152.99)($18.53)($36.08)($60.63)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding61.1M1.4M1.2M1.1M1.0M
Diluted Shares Outstanding61.1M1.4M1.2M1.1M1.0M
Profitability Metrics
EBITDA(266.5M)(209.8M)(21.2M)(37.5M)(61.1M)
D&A96.0K34.0K181.0K830.0K490.0K
EBIT(266.6M)(209.8M)(21.4M)(38.3M)(61.6M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026